Comparative Efficacy (DAS28 Remission) of Targeted Immune Modulators for Rheumatoid Arthritis: A Network Meta-Analysis
mediaposted on 2021-05-24, 17:23 authored by Jennie H. Best, Yuting Kuang, Yilin Jiang, Rajpal Singh, Andreas Karabis, Jennifer Uyei, Joseph Dang, William G. Reiss
Article full text
The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).
© The authors, CC-BY-NC 2021.